Daunorubicin, Cytarabine Liposomes Plus Venetoclax vs Azacitidine Plus Venetoclax in AML Patients Unfit for Intensive Chemotherapy
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
University of Florida
Columbia University
Wake Forest University Health Sciences
Northside Hospital, Inc.
University of Leipzig
Yale University
National Cancer Institute (NCI)
Washington University School of Medicine
Rush University Medical Center
Baptist Health South Florida
Washington University School of Medicine
Yale University
Rush University Medical Center
Kiadis Pharma
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Immune System Key Ltd
Matinas BioPharma Nanotechnologies, Inc.
University of Florida
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
Stanford University
University of Pittsburgh
Jazz Pharmaceuticals
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Eastern Cooperative Oncology Group
Sanofi
Massachusetts General Hospital
Cornerstone Pharmaceuticals
Rutgers, The State University of New Jersey
Eisai Inc.
Mesoblast, Ltd.
Eleos, Inc.
Vanderbilt-Ingram Cancer Center
University of California, San Francisco
University of Cincinnati